HONEY for the Treatment of POst-Tonsillectomy Pain

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorEast and North Hertfordshire NHS Trust

About this trial

Double-blind, randomised, placebo controlled, single-site trial in adults to compare the effect of Manuka honey with standard of care compared to placebo with standard of care on post-tonsillectomy pain and postoperative outcomes.

Main aim is to investigate a potential improvement in post-tonsillectomy pain control, with a low cost and freely available alternative to conventional analgesics. Recent systematic review and multidisciplinary consensus suggest a potential role for the inclusion of honey for this purpose. Clinical efficacy over placebo remains to be conclusively demonstrated in robust clinical trials.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Adult (≥18years old at the time of giving consent)

Consented and listed for bilateral tonsillectomy or adenotonsillectomy

Tonsillectomy performed within the trial study period

Disqualifiers

Any concurrent Head & Neck (H&N) malignancy

Unilateral tonsillectomy

Pregnancy

Concurrent pharyngeal or upper aerodigestive tract biopsy

Trial design

Design model

Parallel

Treatments tested in this trial

  • Manuka honey MGO 1000

    Dietary supplement

    Natural Manuka honey, produced in New Zealand. With MGO content ≥ 1000.

  • Sugar-based syrup, thickened with sodium alginate and flavoured with honey flavouring

    Dietary supplement

    Sugar-based syrup, thickened with sodium alginate and flavoured with honey flavouring, 15ml, three times a day, for 14 days. To be kept on the tongue for at least 10 seconds prior to swallowing.

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: TreatmentExperimental treatment 1 intervention
Group B: PlaceboPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

VAS pain scores

Pain scores as measured on a visual analogue scale 1-10.This is a continuous variable, which will be measured and recorded three times a day, every day for the first 14 days post-tonsillectomy.

Time frame
14 days post-tonsillectomy

Secondary outcomes

1

Number and frequency of concurrent analgesia usage

Patients will be asked record their analgesia administration at home.

Time frame
14 days post-tonsillectomy
2

Rate of readmission to hospital

Retrospective record of re-admission rate

Time frame
14 days post-tonsillectomy
3

Rate of secondary haemorrhage

Retrospective record of secondary haemorrhage rate, defined as any haemorrhage after 24hrs post surgery

Time frame
14 days post-tonsillectomy
4

Rate of infection requiring antibiotics treatment

Retrospective record of any related infection requiring antibiotic treatment

Time frame
14 days post-tonsillectomy

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.